CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368

Search Health Library

Chemotherapy for Thyroid Cancer

Chemotherapy is the use of drugs to kill cancer cells. Unlike radiation therapy and surgery, which are localized treatments, chemotherapy is a systemic treatment. This means that the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have spread, or metastasized, to other areas.

Chemotherapy is rarely used to treat thyroid cancer. It is almost exclusively used when other treatments have failed. If chemotherapy is used, it may be combined with external radiation therapy.

Chemotherapy Drugs Used for Thyroid Cancer

Examples of chemotherapy drugs that may be used to treat thyroid cancer include:

  • Bleomycin
  • Dacarbazine
  • Docetaxel
  • Doxorubicin
  • Paclitaxel
  • Platinum-based agents

Effectiveness

Researchers are still trying to determine what the benefit of chemotherapy is for various stages of thyroid cancer and its metastases. In general, surgery is more important, as is radioablation therapy. When thyroid cancer is unresponsive to these types of treatment, however, chemotherapy with or without external radiation therapy may be tried.

If the thyroid cancer is a highly aggressive form, chemotherapy may improve survival time. Doxorubicin is the most effective single agent in this type of cancer, and it is often combined with radiation treatment.

Adverse Reactions    TOP

In general, the elderly and those with liver and kidney diseases are more likely to have adverse side effects. Therefore, chemotherapy drugs should be used with caution in these populations.

Chemotherapy can cause many side effects, such as:

  • Damage to bone marrow
  • Infertility
  • Lung conditions
  • Heart conditions
  • Kidney conditions
  • Conditions affecting the nervous system
  • Nausea and vomiting
  • Hair loss
  • Diarrhea
  • Bleeding in the gastrointestinal tract
  • Altered taste or smell
  • Mouth sores

Newer Treatment Approaches    TOP

Researchers continue to develop and study different strategies to slow or stop the growth of tumors. For example, a drug called vandetanib has been approved by the Food and Drug Administration (FDA) to treat medullary thyroid carcinoma (MTC). Vandetanib is designed to block the action of certain cell receptors, like the vascular endothelial growth factor (VEGF) receptor. By blocking these receptors, the drug may be able to slow or stop cancer from spreading, as well as shrink tumors.

There are a range of drugs that also inhibit growth factor receptors. The drug cabozantinib, for instance, interferes with the process that cancer cells go through to create new blood vessels, which are needed for the cancer to grow. Other treatments that are being studied include:

  • Pazopanib
  • Axitinib
  • Sunitinib

Another example of targeted therapy includes a drug called vemurafenib. This medicine is designed to treat cancer in people who have a certain mutation in a gene called the BRAF gene. Treatment with vemurafenib has show promise in slowing cancer growth and improving mortality.

PreviousNext

References:

Axitinib. PubMed Health website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol. 2007; 8:148-156
BRAF. Genetics Home Reference website. Available at:
...(Click grey area to select URL)
Updated May 2012. Accessed September 19, 2012.
Cabozantinib. Exelixis website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Cooper DS, Doherty GM, et al. The American Thyroid Association Guidelines Taskforce: management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:1-33.
Cornett WR, Sharma AK, et al. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep. 2007;9:152-158.
Gupta-Abramson V, Troxel AB, et al. Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol. 2008;26(29):4714-9.
Pazopanib. PubMed Health website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Sunitinib. PubMed Health website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Targeted therapy shows benefit in rare type of thyroid cancer. National Cancer Institute website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Targeted therapy for thyroid cancer. American Cancer Society website. Available at:
...(Click grey area to select URL)
Updated January 20, 2012. Accessed September 19, 2012.
Zelboraf. Zelboraf website. Available at:
...(Click grey area to select URL)
Accessed September 19, 2012.
Last reviewed September 2016 by Mohei Abouzied, MD
Last Updated: 9/17/2014

 

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Health Library: Editorial Policy | Privacy Policy | Terms and Conditions | Support
36000 Darnall Loop Fort Hood, Texas 76544-4752 | Phone: (254) 288-8000